The Peptide Report

Vol. 2 · No. 9September 2026

How The Peptide Report Ranks Peptide Telehealth Clinics

Reviewed September 2026. Educational content—not medical advice.

We may have a financial affiliation with some entities featured here. Rankings are editorial.

Scope

The Peptide Report is an independent educational publisher comparing U.S. telehealth brands for physician-guided peptide programs. We are not a clinic, pharmacy, or medical provider; we do not diagnose, prescribe, treat, or “book a consult.” Rank order follows evidence, not affiliation.

Criteria

Tier 1: Trustpilot score, volume, recency, and themes; stable Google Business/Maps evidence. Cite score, count, and date; Google stays TBD until verified. Widgets are not audited scores.

Tier 2: clinician and prescription pathway, named 503A/503B pharmacy, labs, monitoring, and follow-up.

Tier 3: pricing clarity, state/access honesty, waitlist labeling, and restraint. Compounded ≠ FDA-approved.

Exclude paid boosts, fabricated ratings/prices/quotes, predetermined ranks, and unsourced outcomes. Keep TBD and [unverified]; publish at least 10 programs.

Regulatory context

PCAC recommendation ≠ FDA drug approval. Category 2 removal ≠ Category 1 permission. Compounded medications are not FDA-approved; most wellness peptides remain investigational or unapproved.

Disclaimer

Re-verify dated claims on publish day. This is not medical advice, diagnosis, or treatment. Consult a licensed clinician; call 911 for emergencies.

© 2026 The Peptide Report.